Adjunctive treatment of murine neuroblastoma with 6-hydroxydopamine and tempol

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2336-2342

  Purpura, Patti ^a,b   Westman, Laurel ^a,b   Will, Patricia ^a,b   Eidelman, Anthony ^a,b   Kagan, Valerian E ^a   Osipov, Anatoly N ^a   Schor, Nina Felice ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDOPAMINE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CANCER SURVIVAL; DOPAMINE UPTAKE; DOSE RESPONSE; DRUG EFFICACY; DRUG TARGETING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL;

ADRENERGIC AGENTS; ANIMALS; ANTIOXIDANTS; BLEPHAROPTOSIS; CATALASE; CYCLIC N-OXIDES; DOPAMINE; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; IRON; MALE; MICE; MICE, INBRED A; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PEROXIDASE; REACTIVE OXYGEN SPECIES; SINGLE-BLIND METHOD; SPIN LABELS; SYMPATHETIC NERVOUS SYSTEM;

EID: 0029971892     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Pritchard, J., Kiely, E , Rogers, D. W., Spitz, L., Stafford, E. A., Brereton, R., Muller, C , and Wright, V. M. Long term survival after advanced neuroblastoma. N. Engl. J. Med., 317: 1026-1027, 1987
2. Chelmicka-Szorc, E., and Arnason, B. G. W. Effect of 6-hydroxydopamine on tumor growth. Cancer Res., 36: 2382-2384, 1976.
3. Reynolds, C. P., and Perez-Polo, J. R. Ascorbic acid enhances the cytotoxic effect of 6-hydroxydopamine for human neuroblastoma cell lines Neurosci. Lett., 26. 151-155, 1981
4. Tiffany-Castiglioni, E., Saneto, R. P., Proctor, P H., and Perez-Polo, J. R. Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line. Biochem. Pharmacol., 31: 181-188, 1982.
5. Uretsky, N. J., and Iversen, L. L. Effects of 6-hydroxydopamine on noradrenaline-containing neurons in the rat brain. Nature (Lond.), 221. 557-559, 1969.
6. Thoenen, H., and Tranzer, J. P. Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol., 261: 271-288, 1968.
7. Schor, N. F. T. Adjunctive use of Ethiofos (WR2721) with free radical-generating chemotherapeutic agents in mice: new caveats for therapy. Cancer Res., 47: 5411-5414, 1987.
8. Schor, N. F. Mechanisms of synergistic toxicity of the radioprotective agent, WR2721, and 6-hydroxydopamine Biochem. Pharmacol., 37: 1751-1762, 1988.
9. Samuni, A., Krishna, C. M., Mitchell, J. B., Collins, C. R., and Russo, A. Superoxide reaction with nitroxides. Free Radical Res. Commun., 9. 241-249, 1990.
10. Hahn, S. M., Tochner, Z., Murali Krishna, C , Glass, J., Wilson, L., Samuni, A., Sprague, M., Venzon, D., Glatstein, E., Mitchell, J B., and Russo, A. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res., 52: 1750-1753, 1992.
11. Chateauneuf, J , Lusztyk, J., and Ingold, K. U Absolute rate constants for the reactions of some carbon-centered radicals with 2,2,6,6-tetramethylpiperidine-N-oxyl. J. Org Chem , 53: 1629-1632, 1988.
12. Samuni, A., Mitchell, J B , DeGraff, W., Krishna, C. M., Samuni, U., and Russo, A. Nitroxide SOD-mimics: modes of action Free Radical Res. Commun., 12-13: 187-194, 1991.
13. Samuni, A., Winkelsberg, D., Pinson, A., Hahn, S. M., Mitchell, J B , and Russo, A. Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. J. Clin. Invest., 87: 1526-1530, 1991.
14. Will, P., Guger, K. A , and Schor, N. F. Effects of neocarzinostatin upon the development of tumors from murine neuroblastoma cells Cancer Chemother. Pharmacol., 35: 115-120, 1995.
15. Schor, N. F. Neocarzinostatin induces neuronal morphology of mouse neuroblastoma in culture. J. Pharmacol. Exp. Ther., 249: 906-910, 1989.
16. Siegel, S. Nonparametric Statistics. New York: McGraw-Hill, Inc., 1956.
17. Iannone, A., Bini, A., Swartz, H. M., Tomasi, A., and Vannini, V. Metabolism in rat liver microsomes of the nitroxide spin probe Tempol. Biochem. Pharmacol., 38: 2581-2586, 1989
18. Sachs, A., and Johnson, G. Mechanisms of action of 6-hydroxydopamine. Biochem. Pharmacol., 24: 1-8, 1975
19. Schor, N. F. Targeted enhancement of the biological activity of the antineoplastic agent, neocarzinostatin: studies in murine neuroblastoma cells. J. Clin. Invest., 89: 774-781, 1992.
20. Giunta, S., Galeazzi, L., and Groppa, G. An in vitro model of cytotoxicity to living cells caused by dopamine and 6-hydroxydopamine oxidation at physiologcal pH. Free Radical Biol. & Med., 10. 297-303, 1991.
21. Gee, P., and Davison, A. J. 6-Hydroxydopamine does not reduce molecular oxygen directly, but requires a coreductant. Arch. Biochem. Biophys. 231: 164-168, 1984.
22. Halliwell, B., and Gutteridge, J M. C Free Radicals in Biology and Medicine. Oxford, United Kingdom: Clarendon Press, 1989.
23. Mitchell, J. B., Samuni, A , Krishna, M. C , DeGraff, W. G., Ahn, M. S., Samuni, U., and Russo, A. Biologically active metal-independent superoxide dismutase mimics. Biochemistry, 29. 2802-2807, 1990.